• Corpus ID: 45513644

Ascorbic Acid and Dehydroascorbic Acid Concentrations in Plasma and Peripheral Blood Mononuclear Cells after Oral Liposomal-Encapsulated or Intravenous Ascorbic Acid Delivery

  title={Ascorbic Acid and Dehydroascorbic Acid Concentrations in Plasma and Peripheral Blood Mononuclear Cells after Oral Liposomal-Encapsulated or Intravenous Ascorbic Acid Delivery},
  author={Nina A. Mikirova},
Background The importance of consumption of vitamin C (ascorbic acid) for human health is well known, as adequate availability of vitamin C is necessary for proper immune functioning, suppression of virus replication, suppression of inflammation, and in the process of healing in many chronic diseases. The oral route is the most convenient way to administer vitamin C. However, it has been shown that plasma ascorbic acid levels following oral administration are tightly controlled. A different… 
1 Citations

Figures from this paper

Fiber-Reinforced-Phospholipid Vehicle-Based Delivery of l-Ascorbic Acid: Development, Characterization, ADMET Profiling, and Efficacy by a Randomized, Single-Dose, Crossover Oral Bioavailability Study

The results show that a single oral dose of Zeal-AA is capable of rising the AA levels in the body relative to the control up to 24 h, and optimize the oral bioavailability of the obtained AA powder using an efficacy study using an open-label, randomized, single-dose, two-treatment, three-sequence, and two-period crossover.



Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients.

The findings indicate that antioxidant defenses could be considerably compromised in these very sick patients and the potential of these species to damage DNA and lipid membranes could be increased and compromise recovery.

The effect of ascorbic acid supplementation on some parameters of the human immunological defence system.

  • W. PrinzR. BortzB. BreginM. Hersch
  • Medicine, Biology
    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition
  • 1977
It was shown that ascorbic acid supplementation caused a statistically significant increase in the serum levels of IgA, IgM and C-3 complement, and the study does not permit of conclusions regarding the mechanisms of action of ascorBic acid.

Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use

It is reported here that intravenous doses can produce plasma concentrations 30- to 70-fold higher than the maximum tolerated oral doses, and the role of vitamin C in cancer treatment should be reexamined, and insights from vitamin C pharmacokinetics can guide its clinical use.

Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.

The range of vitamin C concentrations possible in humans, pharmacokinetics studies were conducted and showed that when vitamin C is ingested by mouth, plasma and tissue concentrations are tightly controlled by at least 3 mechanisms in healthy humans: absorption, tissue accumulation, and renal re absorption.

Human vitamin C (L-ascorbic acid) transporter SVCT1.

The molecular cloning of a novel human cDNA encoding a vitamin C transporter SVCT1 is described and it is demonstrated that the human SLC23A1 gene product is a related high-affinity l-ascorbic acid transporter (SVCT2) that is widely distributed in brain, retina, and a host of endocrine and neuroendocrine tissues.

Oral administration of insulin by encapsulation within liposomes

Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

The current RDA of 60 mg daily should be increased to 200 mg daily, which can be obtained from fruits and vegetables, and safe doses of vitamin C are less than 1000mg daily, and vitamin C daily doses above 400 mg have no evident value.

The stability of liposomes in vitro to pH, bile salts and pancreatic lipase.

Clinical and Experimental Experiences with Intravenous Vitamin C

All in vitro studies described herein used sodium ascorbate and intravenous vitamin C references herein refer to the use of vitamin C for injection produced by Steris Laboratories, or American Regent laboratories; both are asCorbic acid buffered to a pH range of 5.5 to 7.0 by sodium hydroxide and/or sodium bicarbonate.